Evotec.
company
- Reports this week
- 1
- Active events
- 1
- Connections
- 47
What's happening
Active this week
One to three months ago
-
SVA collaborates with Evotec on developing bio-hybrid organs.Some support1 report
-
Evotec was listed on the stock exchange and received rating changes from Berenberg Bank and TD Cowen.Some support2 reports
-
Both Revvity and Evotec are healthcare companies operating in the biotech sector.Some support3 reports
-
Evotec has formed a strategic R&D collaboration with Odyssey Therapeutics, Inc.Some support1 report
-
Waters Corporation and Evotec are being compared as healthcare companies in the market.Some support2 reports
-
Evotec and Ginkgo Bioworks are both small-cap healthcare companies.Some support1 report
-
TD Cowen and Berenberg Bank issued rating changes for Evotec.Some support4 reports
Gone quiet
No new reports in 90+ days-
Sandoz and Evotec announced a strategic partnership and potential sale of the Just - Evotec Biologics EU site in Toulouse.Some support1 report2 developments inside
-
Sandoz is facing issues regarding the absence of licensing payments related to the strategic partnership with Evotec.Some support1 report
-
Evotec, Bristol Myers Squibb, and Sandoz announced the evolution of their strategic partnership and financial results from Hamburg.Some support3 reports2 developments inside
-
Evotec successfully lists on Nasdaq and validates its model through a transaction with Sandoz, building on its partnership with Sandoz.Some support2 reports
-
Evotec has 18 production sites, which are mainly located in Europe and the United States.Speculative1 report
-
An event involving Evo and Evotec began on June 25, 2025.Speculative1 report
-
Evotec received a grant from the Gates Foundation.Speculative1 report
-
Evotec maintains an office in Hamburg, operating within Germany.Well supported5 reports
-
Sandoz assumes full ownership of the Evotec Biologics site in Toulouse.Some support1 report
-
Evotec and LabCorp are key players in the field of drug discovery services.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Evotec this week
News at the entities that move Evotec most-
TD Cowen OperationalTD Cowen reiterated a buy rating on MBX Biosciences shares, and Citigroup restated an outperform rating on the company.Moves Evotec
-
Berenberg Bank OperationalRating upgrades and restatements on ASML shares, including an upgrade from hold to strong-buy, were announced.Moves Evotec
-
Bristol-Myers Squibb OperationalCompanies are pouring billions into protein degraders, a drug class that has received FDA approval and is being discussed by ASCO.Moves Evotec
-
BAYER OperationalSean Maenpaa, with experience at Novartis and Celgene, was appointed SVP Business Development at Clovis Oncology.Moves Evotec
-
Nasdaq StructuralApple Inc. debuted its new foldable smartphone on September 10, 2026.Moves Evotec
-
MarketBeat Mentioned togetherMarketBeat reports average rating and reduced price target for PNC stock.Moves Evotec
Connections
The 18 strongest of 47, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Sandoz Structural
Sandoz assumed full ownership of Evotec's site following a strategic partnership and transaction.
-
TD Cowen Operational
TD Cowen provides investment ratings and analysis on Evotec, actively influencing its market perception.
-
Bristol-Myers Squibb Operational
Evotec and Bristol-Myers Squibb maintain a strategic partnership focused on drug discovery, including molecular glue degraders and targeted protein degradation.
-
BAYER Operational
The companies are actively collaborating on shared drug discovery projects.
-
Holbrook Structural
Holbrook holds the position of Chief Scientific Officer (CSO) at Evotec.
-
Nasdaq Structural
Evotec is formally listed and trades on the Nasdaq stock exchange.
-
Berenberg Bank Operational
Berenberg Bank actively issues and modifies stock ratings for Evotec, influencing its market status.
-
Navan Operational
The two entities have formed an active partnership.
Show all 18 connections
-
MarketBeat Mentioned together
MarketBeat provides average stock ratings for Evotec.
-
Ginkgo Bioworks Operational
Both companies are small-cap peers actively competing within the healthcare market.
-
Hallbergmoos Transactional
A collaboration was announced between the entities while located in Hallbergmoos.
-
Hamburg Shared context
Evotec operates from and is headquartered in Hamburg.
-
Reuters Mentioned together
Reuters reported on the outlook cut announced by Evotec.
-
Waters Corporation Mentioned together
The companies are co-mentioned in market analysis due to their shared status as healthcare companies.
-
SVA Operational
SVA and Evotec are collaborating on the development of bio-hybrid organs.
-
Revvity Shared context
Both companies operate within the shared context of the competitive biotech healthcare sector.
-
Toulouse Shared context
Evotec operates a site within the city of Toulouse.
-
Sandoz Transactional
The relationship is defined by a licensing payment agreement between Sandoz and Evotec.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
1 eventAugust 2026
5 events- Evotec was listed on the stock exchange and received rating changes from Berenberg Bank and TD Cowen.
- Both Revvity and Evotec are healthcare companies operating in the biotech sector.
- Evotec has formed a strategic R&D collaboration with Odyssey Therapeutics, Inc.
- Waters Corporation and Evotec are being compared as healthcare companies in the market.
- Evotec and Ginkgo Bioworks are both small-cap healthcare companies.
Show 2 earlier months
July 2026
2 eventsJune 2026
9 events- Sandoz and Evotec announced a strategic partnership and potential sale of the Just - Evotec Biologics EU site in Toulouse.
- Evotec, Bristol Myers Squibb, and Sandoz announced the evolution of their strategic partnership and financial results from Hamburg.
- Evotec successfully lists on Nasdaq and validates its model through a transaction with Sandoz, building on its partnership with Sandoz.
- Evotec has 18 production sites, which are mainly located in Europe and the United States.
- An event involving Evo and Evotec began on June 25, 2025.
- Evotec received a grant from the Gates Foundation.
- Evotec maintains an office in Hamburg, operating within Germany.
- Sandoz assumes full ownership of the Evotec Biologics site in Toulouse.
- Evotec and LabCorp are key players in the field of drug discovery services.